See also this year's filing and all EDGAR filings for this company.
PDF Report 0000849636_2019_RespireRx_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000849636')"} |
Graph
Absolute values for 0000849636, RespireRx Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 121,076 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 3,114 |
| 4 | LiabilitiesCurrent | 5,857,445 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,488,238 |
| 9 | ResearchAndDevelopmentExpense | 688,286 |
| 10 | remainder_Expenses | 302,625 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -112,641 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 124,190 |
| 1 | Liabilities | 5,857,445 |
| 2 | Expenses | 2,479,149 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -5,733,255 |
| 5 | NetIncome | -2,591,790 |
| 6 | ComprehensiveNetIncome | -2,591,790 |
| 7 | BaseVar | 4,286,712 |
| 8 | EconomicCapitalRatio | -4.16 |